LSSOT Banner


Each year, the LSSOT holds an Annual Meeting as a means to present scientific and educational programs in contemporary issues in toxicology. One of the main purposes of this Annual Meeting is to provide a venue in which students at all levels can present their work and receive constructive feedback on their projects. Awards for student poster and platform presentations are given.

Upcoming Meeting

Lone Star Regional Chapter of the Society of Toxicology—2019 Annual Fall Meeting

Online Registration

Registration Dates 10/12–11/13 11/14–11/15
Standard On-Site
Full Members/Senior Level Scientists $75.00 $85.00
Postdoctoral Fellows/Graduate Students $50.00 $60.00
Undergraduate Students $35.00 $45.00
Non-SOT/LSSOT members $100.00 $110.00

November 14–15, 2019
University of Texas Medical Branch
Tremont Davidson Ballroom at the Tremont House Hotel
Galveston, Texas

Online registration is now open for the 2019 LSSOT fall meeting on November 14–15, 2019 University of Texas Medical Branch/Tremont House Hotel in Galveston, TX. Please follow the link below to register for the meeting. When registering, please be sure to use your SOT member login or to create an account if a nonmember. From the registration page, please be sure to select your registration type from the dropdown and then also select the options listed under sessions. Once this page is complete, please click the continue button to proceed to review and then payment. Please do NOT click the Save & Add Guest option; this is for the National SOT and does not apply to our meeting.

Online Registration Link

Registration fees will increase based on the date so please be sure to register early! The registration costs can be found below.

Registration Dates 9/18–10/11 10/12–11/13 11/14–11/15
Early Standard On-Site
Full Members/Senior Level Scientists $65.00 $75.00 $85.00
Postdoctoral Fellows/Graduate Students $40.00 $50.00 $60.00
Undergraduate Students $25.00 $35.00 $45.00
Non-SOT/LSSOT members $90.00 $100.00 $110.00

For abstract submission, please go to the link below. then enter the following code: EXELLMLM4


Alternatively, if you have a device that has an app capable of reading QR codes, you may scan the QR code below, which should take you directly to the survey in a web browser.

During abstract submission, you may save and return to the submission. The survey will provide you with an individual return code similar to the one you used above. Please write this down before closing the page. If you should lose or misplace the individual code, please contact Dr. Lance Hallberg at and he will retrieve your return code for you.

ABSTRACTS ARE DUE BY October 18, 2019

The LSSOT Committee will review each abstract that is submitted. The following are the SOT standards for abstract acceptance. The following SOT guidelines apply to each abstract:
< 2,300 Total Characters
Including the title, body, author last name, and institutions. Spaces are not included in the character count.

  • NO Tables, Figures, or Chemical Structures
  • Avoid Headers
    • Do not use headers such as "Introduction," "Background," etc.
  • All Nonstandard Acronyms should be Defined
  • All Presenters Agree to Accept Assignment to either “Oral” or “Poster” Session, at the LSSOT Committee’s Discretion
  • All Presenters Must Register and Pay to Attend the LSSOT Annual Meeting

For acceptance, abstracts describing the results of experimental studies must answer two questions (“What was done?” and “What was found?”) and must contain the following:

  • A statement of the rationale and scope of the study presented
  • A brief description of the experimental procedures
  • The data that resulted from the study
  • The principal conclusion(s) based on interpretation of the results

Additionally, authors should consider the following when developing the abstract:

  • Test compounds utilized in the study should be identified in the abstract. In cases where the length of the proper chemical name precludes its use, a manufacturer’s identification number, etc., may be acceptable, provided the structure and chemical identity of the compound are included in the presentation. Abstracts will not be accepted if the authors are unable to disclose the chemical identity of the compound(s) used in the study.
  • When describing your research or assessment approaches, please refrain from using introductory phrases such as “will be presented.” Phrases such as “results/data will be discussed” convey no information as to the outcome of the studies and are unacceptable.
  • It can be challenging to describe results of “big data” studies within the confines of a 2,300-character abstract. Instead, include specific examples of findings to help meet the requirement for description of data.
  • All animal experimentation must be carried out in accordance with the Society’s Guiding Principles in the Use of Animals in Toxicology .
  • All abstracts submitted with human testing require that IRB protocol has been followed and approval obtained.

In the case of studies that do not describe laboratory or field experiments, such as reports on educational, ethics, legal, or social initiatives, authors should:

  • Describe the research or assessment approach instead of experimental procedures.
  • Summarize the study’s results or findings explicitly.
  • Clearly articulate the implications for stakeholders.

In addition, abstracts describing new initiatives or science policy in the regulatory community must clearly describe the impact on the practice of toxicology and/or risk assessment. Care should be taken to clearly distinguish between statements based on documented facts versus opinions. Literature surveys or reviews and background materials are insufficient in and of themselves.



Past Meetings »